Evidence map›Paper›PMID 36891011›Full record

ArticleCureus2023

Asymptomatic Hyperuricemia as an Independent Risk Factor for Myocardial Infarction in Adult Population: A Four-Year Follow-Up Study.

Abdul Subhan Talpur, Abdul Fattah, Hewad Hewadmal, Farukhzad Hafizyar, Jawad Farooq, Tanveer Ahamad Shaik, Laila Tul Qadar, Syed Muhammad Hussain Zaidi, Sarmad Pirzada, Abdul Rasheed Bahar

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Gout in pregnancy: Obstetric and neonatal outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Abdul Subhan TalpurMedicine, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.
Abdul FattahInternal Medicine, Indus Medical College, Tando Muhammad Khan, PAK.
Hewad HewadmalCardiology, Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, PAK.
Farukhzad HafizyarInternal Medicine, Liaquatian Research Council, Hyderabad, PAK.
Jawad FarooqMedicine, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.
Tanveer Ahamad ShaikCardiovascular Medicine, University of Louisville School of Medicine, Louisville, USA.
Laila Tul QadarInternal Medicine, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.
Syed Muhammad Hussain ZaidiInternal Medicine, Dow University of Health Sciences, Karachi, PAK.
Sarmad PirzadaInternal Medicine, Trinity Health Livonia, Livonia, USA.
Abdul Rasheed BaharInternal Medicine, Liaquatian Research Council, Hyderabad, PAK.
Civil Hospital Karachi · PKDow University of Health Sciences · PKIndus Hospital · PKLiaquat University of Medical & Health Sciences · PKShaikh Zayed Medical College and Hospital · PKTrinity Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction A condition in which uric acid levels are elevated but there are no accompanying symptoms is known as asymptomatic hyperuricemia. As a result of the disparity in opinions and findings between the studies, the guidelines regarding whether or not asymptomatic hyperuricemia should be treated are unclear. Material and methods Between the months of January 2017 and June 2022, this research was carried out in the community in collaboration with the internal medicine unit and the public health unit of Liaquat University of Medical and Health Sciences. After obtaining informed consent from each participant, the researchers enrolled 1,500 patients in the study who had uric acid levels that were greater than 7.0 mg/dL. These patients ranged in age from 40 to 70 years old and were of either gender. As a control group, 1,500 patients were recruited who did not have abnormally high levels of uric acid. Patients were monitored for a total of 48 months or until the occurrence of a major cardiovascular event (MACCE) or death from all causes, whichever occurred first. Death, cardiovascular mortality, non-fatal myocardial infarction, and non-fatal stroke were the four categories that made up the primary outcome, also known as MACCEs. Results In the hyperuricemic group, the incidence of myocardial infarction that did not result in death was significantly higher than in the non-hyperuricemic group (1.6% vs. 0.7%; p-value, 0.04). However, the result was not significant for deaths from all causes, deaths from cardiovascular disease, or strokes that did not result in death. Conclusion Asymptomatic hyperuricemia is a potential threat to one's health that can lead to cardiovascular diseases and may go undiagnosed in some cases. It is important to remember that hyperuricemia can lead to delirious complications, so efforts should be made to perform routine monitoring and management of the condition.

Indexed as

acute myocardial infarction in pakistancardiac risk factors and preventionelevated uric acid levelsfatal myocardial infarctionnon-fatal myocardial infarction

Identifiers

PMID36891011
PMCPMC9986685
OpenAlexW4319229859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.